Skip to content

Write a review and win an AirPods Pro or MacBook Air - See the draw

Verified

Full-service CRO

Lambda Therapeutic Research

Bioequivalence and early-phase CRO with deep expertise in generic drug development,pharmacokinetic studies,and regulatory submissions for ANDA and NDA pathways.

Big CRO

Vendor description

About

Bioequivalence and early-phase CRO with deep expertise in generic drug development,pharmacokinetic studies,and regulatory submissions for ANDA and NDA pathways.

Positioning

Best suited for sponsors that need full-service cro support across global programmes.

Best for

Sponsors seeking bioequivalence and early phase trials.

Strengths
  • Bioequivalence and early phase trials
  • Coverage listed as Global
  • Therapeutic/service focus includes Bioequivalence,Early Phase
Limitations
  • Controlled prototype-to-canonical import only; scoring and deeper evidence enrichment still pending.

Approved customer reviews

Write a review
No reviews yet

Be the first customer to share verified experience with this vendor.

Review snapshot

External review summary

Public evidence capture initiated separately in reviews_online_signals_v1.json.

Pricing

Price band

$

Key facts

HQ countryIndia
GeographyGlobal
Service modelSpecialist CRO
Customer segmentmixed
Study phasesPhase I
Trial scaleMid-size to large global programmes
Therapeutic areasBioequivalence, Early Phase
Last reviewed2026-03-22

Related vendors

Editorial ranking

See how Lambda Therapeutic Research compares - best Full-service CRO vendors for clinical trials.